BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park YB, Rhee CK, Yoon HK, Oh YM, Lim SY, Lee JH, Yoo KH, Ahn JH; Committee of the Korean COPD Guideline 2018. Revised (2018) COPD Clinical Practice Guideline of the Korean Academy of Tuberculosis and Respiratory Disease: A Summary. Tuberc Respir Dis (Seoul) 2018;81:261-73. [PMID: 29926554 DOI: 10.4046/trd.2018.0029] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Ma L, Gao M. Analysis of Clinical Characteristics and Risk Factors for Drug Resistance in Newly-Treated Patients with Pulmonary Tuberculosis Complicated with Chronic Obstructive Pulmonary Disease. Infect Drug Resist 2022;15:4861-9. [PMID: 36045874 DOI: 10.2147/IDR.S358121] [Reference Citation Analysis]
2 Choi JY, Lim SY, Yun SY. [Knowledge Structure of Chronic Obstructive Pulmonary Disease Health Information on Health-Related Websites and Patients' Needs in the Literature Using Text Network Analysis]. J Korean Acad Nurs 2021;51:720-31. [PMID: 35023860 DOI: 10.4040/jkan.21086] [Reference Citation Analysis]
3 Choi YJ, Kwon DS, Kim T, Cho JH, Kim HJ, Byun MK, Park HJ. Low alanine aminotransferase as a risk factor for chronic obstructive pulmonary disease in males. Sci Rep 2021;11:14829. [PMID: 34290312 DOI: 10.1038/s41598-021-94385-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Cheng SL, Lin CH. COPD Guidelines in the Asia-Pacific Regions: Similarities and Differences. Diagnostics (Basel) 2021;11:1153. [PMID: 34202503 DOI: 10.3390/diagnostics11071153] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
5 Park YB, Yoo KH. The current status of chronic obstructive pulmonary disease awareness, treatments, and plans for improvement in South Korea: a narrative review. J Thorac Dis 2021;13:3898-906. [PMID: 34277079 DOI: 10.21037/jtd-21-172] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
6 Jang JG, Chung JH, Shin KC, Jin HJ, Lee KH, Ahn JH. Comparative Study of Inhaler Device Handling Technique and Risk Factors for Critical Inhaler Errors in Korean COPD Patients. Int J Chron Obstruct Pulmon Dis 2021;16:1051-9. [PMID: 33907392 DOI: 10.2147/COPD.S303761] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Park HJ, Rhee CK, Yoo KH, Park YB. Reliability of Portable Spirometry Performed in the Korea National Health and Nutrition Examination Survey Compared to Conventional Spirometry. Tuberc Respir Dis (Seoul) 2021. [PMID: 33940672 DOI: 10.4046/trd.2021.0016] [Reference Citation Analysis]
8 Kim DK, Rhee CK. Updated view on the treatment of chronic obstructive pulmonary disease in Korea. J Korean Med Assoc 2021;64:225-31. [DOI: 10.5124/jkma.2021.64.3.225] [Reference Citation Analysis]
9 Lee SH, Rhee CK, Yoo K, Park JW, Yong SJ, Kim J, Lee T, Lim SY, Lee JH, Park HY, Moon M, Jung KS. Direct Switch from Tiotropium to Indacaterol/Glycopyrronium in Chronic Obstructive Pulmonary Disease Patients in Korea. Tuberc Respir Dis (Seoul) 2021;84:96-104. [PMID: 33352035 DOI: 10.4046/trd.2020.0109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Han H, Oh EY, Lee JH, Park JW, Park HJ. Effects of Particulate Matter 10 Inhalation on Lung Tissue RNA expression in a Murine Model. Tuberc Respir Dis (Seoul) 2021;84:55-66. [PMID: 33253518 DOI: 10.4046/trd.2020.0107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
11 Kwon DS, Choi YJ, Kim TH, Byun MK, Cho JH, Kim HJ, Park HJ. FEF25-75% Values in Patients with Normal Lung Function Can Predict the Development of Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2020;15:2913-21. [PMID: 33209020 DOI: 10.2147/COPD.S261732] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
12 Deshmukh K, Khanna A. Implications of Managing Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases. Tuberc Respir Dis (Seoul) 2021;84:35-45. [PMID: 33045814 DOI: 10.4046/trd.2020.0088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
13 Lee HY, Song JH, Won HK, Park Y, Chung KB, Lim HJ, Ahn YM, Lee BJ. Comparing Inhaler Use Technique Based on Inhaler Type in Elderly Patients with Respiratory Disease. Tuberc Respir Dis (Seoul) 2021;84:46-54. [PMID: 32981292 DOI: 10.4046/trd.2020.0021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Kong Q, Mo S, Wang W, Tang Z, Wei Y, Du Y, Liu B, Kong L, Lv Y, Dong J. Efficacy and safety of Jia Wei Bushen Yiqi formulas as an adjunct therapy to systemic glucocorticoids on acute exacerbation of COPD: study protocol for a randomized, double-blinded, multi-center, placebo-controlled clinical trial. Trials 2020;21:760. [PMID: 32883322 DOI: 10.1186/s13063-020-04669-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Jo YS, Yoo KH, Park YB, Rhee CK, Jung KS, Jang SH, Park JY, Kim Y, Kim BY, Ahn SI, Jo YU, Hwang YI. Relationship Between Changes in Inhalation Treatment Level and Exacerbation of Chronic Obstructive Pulmonary Disease: Nationwide the Health Insurance and Assessment Service Database. Int J Chron Obstruct Pulmon Dis 2020;15:1367-75. [PMID: 32606646 DOI: 10.2147/COPD.S248616] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Lee KS, Kim KH, Oh YM, Han B, Kim WJ. A genome wide association study for lung function in the Korean population using an exome array. Korean J Intern Med 2021;36:S142-50. [PMID: 32336055 DOI: 10.3904/kjim.2019.204] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Hwang JJ, Oh YM, Rhee CK, Yoo KH, Park YB, Yoon HI, Lim SY, Lee JH, Kim EK, Kim TH, Lee SW, Lee SD, Lee JS; KOLD Group. Hyperuricemia Is Not Predictive of Long-Term Outcome in Patients with Stable Chronic Obstructive Pulmonary Disease. J Korean Med Sci 2020;35:e58. [PMID: 32103646 DOI: 10.3346/jkms.2020.35.e58] [Reference Citation Analysis]
18 Lee JK, Rhee CK, Kim K, Ra SW, Lee JH, Jung KS, Yoo KH, Kim YI, Kim DK. Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis 2019;14:2639-47. [PMID: 31819397 DOI: 10.2147/COPD.S216326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Hwang YI. Reducing chronic obstructive pulmonary disease mortality in Korea: early diagnosis matters. Korean J Intern Med 2019;34:1212-4. [PMID: 31671926 DOI: 10.3904/kjim.2019.327] [Reference Citation Analysis]
20 Kim TO, Shin HJ, Kim YI, Rhee CK, Lee WY, Lim SY, Ra SW, Jung KS, Yoo KH, Park SJ, Lim SC. Adherence to the GOLD Guideline in COPD Management of South Korea: Findings from KOCOSS Study 2011-2018. Chonnam Med J 2019;55:47-53. [PMID: 30740340 DOI: 10.4068/cmj.2019.55.1.47] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
21 Lewthwaite H, Williams G, Baldock KL, Williams MT. Systematic Review of Pain in Clinical Practice Guidelines for Management of COPD: A Case for Including Chronic Pain? Healthcare (Basel) 2019;7:E15. [PMID: 30678205 DOI: 10.3390/healthcare7010015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]